medigraphic.com

2004, Number 1

<< Back Next >>

Arch Cardiol Mex 2004; 74 (1)

Results of surgical treatment of congenital heart defects in children with Down´s syndrome

Calderón-Colmenero J, Flores A, Ramírez S, Patiño-Bahena E, Zabal C, García-Montes JA, Rizo S, Buendía A, Attie F

Language: Spanish
References: 18
Page: 39-44
PDF size: 64.51 Kb.


ABSTRACT

We made a retrospective study of patients with Down’s syndrome that were surgically treated for correction or paliation for their congenital heart disease between january 1996 to december of the 2000 in the National Institute of Cardiology “Ignacio Chávez”. We analyzed these variables: age at the surgical moment, sex, congenital heart defect, pulmonary arterial pressure, type of surgery, time of stay in the intensive care unit, complications and mortality. In this period they were surgically treated 37 patients. The mean age was of 2 years with 8 months with a range of 2 months to 17 years. The interventricular defect was the most frequent one (35%) and it was associated to persistent ductus arteriosus in the 61% of the cases. Six patients(16%) had atrioventricular septal defect, the half of them type A and other half type C of Rastelli classification. Twelve patients (32%) had one lesion persistent ductus arteriosus. Three patients had tetralogy of Fallot and two atrial septal defect. Pulmonary hypertension was found in 90% of the patients, in 23 was severe (62%), moderate in 5 and slight in 6 (16%). The surgical treatment was corrective in 89% patients and the average time of stay in intensive care unit was of 2.5 days. The most frequent complication was rhythm and conduction disorders, in 8 patients (22%), three with complete AV block and the mortality was of 8%. In the patients with Down´s syndrome is important a complete clinical evaluation with an eye toward establishing an opportune surgical treatment.


REFERENCES

  1. Leck I: Incidence and epidemicity of Down´s Syndrome. Lancet 1966; 2: 457-460.

  2. Laursen HB: Congenital Heart disease in Down’s Syndrome. Br Heart J 1976; 38: 32-37.

  3. Borowski A, Zeuchner M, Schickendantz S, Korb H: Down syndrome as a factor influencing hemodynamic response to pulmonary artery banding. Pediatr Cardiol 1996; 17: 375-81.

  4. Fuentes JJ, Pritchard MA, Planas AM, Bosch A, Ferrer I, Estivill X: A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Hum Mol Genet 1995; 4: 1935-1944.

  5. Malec E, Mrocsek T, Pajak J, Januszewska K, Zdebska E: Results of surgical treatment of congenital heart defects in children with Down´s syndrome. Pediatr Cardiol 1999; 20: 351-354.

  6. Mathew P, Moodie D, Sterba R, Murphy D, Rosenkranz E, Homa A: Long-term follow-up of children with Down syndrome with cardiac lesions. Clin Pediatr 1990; 29: 569-74.

  7. Park SC, Mathews RA, Zuberbuhler JR, Rowe RD, Neches WH, Lenox CC: Down syndrome with congenital heart malformation. Am J Dis Child 1977; 131: 29-33.

  8. Reller MD, Morris CD: Is Down syndrome a risk factor for poor outcome after repair of congenital heart defects? J Pediatr 1998; 132: 738-741.

  9. Rowe RD, Uchida IA: Cardiac malformation in mongolism: A prospective study of 184 mongoloid children. Am J Med 1961; 31: 726-735.

  10. Suzuki K, Yamaki S, Mimori S, Murakami Y, Mori K, TakahashinY, Kikuchi T: Pulmonary vascular disease in Down’s syndrome with complete atrioventricular septal defect. Am J Cardiol 2000; 86: 434-437.

  11. Wilson NJ, Gordon Culham JA, Sandor GGS, Taylor GP: Pulmonary wedge angiography for prediction of pulmonary vascular disease in Down’s syndrome. Cather Cardiol Diagn 1993; 28: 22-33.

  12. Schneider DS, Zahka KG, Clark EB, Neill CA: The Baltimore-Washington Infant Study group patterns of cardiac care in infants with Down’s syndrome. AJDC 1989; 143: 363-365.

  13. Towbin J, Greenberg F: Genetic syndromes and clinical molecular genetics. En: The Science and Practice of Pediatric Cardiology. Baltimore. Williams & Williams 1998: 2627-2639.

  14. Reeves R: Recounting a genetic story. Nature 2000; 405: 283-284.

  15. Marino B, Diglio C: Congenital heart disease and syndromes specific correlation between cardiac phenotype and genotype. Cardiovascular Pathology 2002; 9: 303-315.

  16. Koremberbg J, Barlow G, Chen X-N: Down’s syndrome congenital heart disease: narrowed region DSCAM as a candidate gene. En: Clark E, Nakazawa M, Takao A Ed’s. Etiology and morphogenesis of congenital heart disease. Armonk, NY. Futura Publishing 2000: 365-369.

  17. Buendía A, Calderón-Colmenero J, Patiño E, Ramírez S, Zabal C, Muñoz L, Attie F: Síndromes asociados a cardiopatías congénitas. PLAC CARDIO-3. México. Intersistemas. 2002: 522-526.

  18. Mendoza G, Calderón J, Buendía A: Síndrome de Down y cardiopatías congénitas. Experiencia quirúrgica en la población infantil del “INCICH”. México. Tesis Especialidad en Cardiología Pediátrica UNAM. 1998.




2020     |     www.medigraphic.com